Specifically, the MHRA approved Zynyz as a first- and second-line treatment for adults with advanced squamous cell carcinoma ...

Earlier this year I was sent a certificate showing 99.6% purity. It had a lab name, a test date, and a clean chromatogram. It ...

The approval gives Lilly first-mover advantage in China – the world's second-largest pharma market – and an edge over Novo, ...

Reports are emerging that the Commissioner's National Priority Voucher (CNPV) scheme launched by former FDA Commissioner ...

Private equity firm Blackstone Life Sciences has agreed to provide up to $1.5 billion in funding to Pfizer for the ...

Ahead of World Diabetes Day on Saturday, Novo has said it will provide $200 million over the next 10 years to support World ...

UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...

Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...

The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...

Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...

Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...

The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...